Eduardo Bruera is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 1,904 publications with 77,483 citations (h-index 129); ClinicalTrials.gov lists 12 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304009
Telephone
713-792-6161Registry record last updated 5 Jul 2012.
Clinical trials
- Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
Sponsor: M.D. Anderson Cancer Center
- Cordotomy in Reducing Pain in Patients With Advanced Cancer
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
61%Opioid Agonist31.7%Morphine Sulfate Er54%Oxycodone Hcl46%Part D<11 patientsAtypical Antipsychotic29.3%Olanzapine100%Part D≥17 patientsRespiratory
22%Opioid Agonist22%Hydrocodone-Acetaminophen100%Part D≥15 patientsMetabolism & gastrointestinal
17.1%Dopamine-2 Receptor Antagonist17.1%Metoclopramide Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2006–2009 per NIH RePORTER. The latest:
- Parenteral Hydration in Advanced Cancer Patients: A Randomized Controlled Trial
University of Tx Md Anderson Can Ctr
FY2009$423,396R01CA122292 - Morphine versus Methadone as First Line Strong Opioid for Cancer Pain
University of Tx Md Anderson Can Ctr
FY2009$412,235R01CA124481 - Methylphenidate for Fatigue in Advanced Cancer Patients
University of Tx Md Anderson Can Ctr
FY2009$355,830R01NR010162
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Journal of Clinical Oncology
2022 - Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
Journal of Clinical Oncology
2022 - Redefining Palliative Care—A New Consensus-Based Definition
Journal of Pain and Symptom Management
2020 - A Comparison of Burnout Frequency Among Oncology Physicians and Nurses Working on the Frontline and Usual Wards During the COVID-19 Epidemic in Wuhan, China
Journal of Pain and Symptom Management
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”